← Back to Search

Mindfulness & Tai Chi for Cancer Health (MATCH Trial)

N/A
Waitlist Available
Led By Linda E Carlson, PhD
Research Sponsored by Linda E. Carlson
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention, within 3 weeks of completion of the intervention, 6-month follow up from intervention completion
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether mindfulness-based cancer recovery or Tai chi/Qigong are more effective than usual care in improving quality of life for cancer survivors.

Who is the study for?
This trial is for adults over 18 who've had cancer (stage I-III, excluding head, neck, or brain), finished active treatment at least 4 months ago, and can attend classes. They should be able to do light physical activity and speak English well enough for questionnaires and groups. It's not for those with severe mental health issues, cognitive impairments, metastatic cancer patients on chemotherapy, or those already practicing meditation or tai chi weekly.
What is being tested?
The MATCH Study compares Mindfulness-Based Cancer Recovery (MBCR) and Tai Chi/Qigong (TCQ) against a waitlist control to see which improves quality of life after cancer. Participants either choose their preferred method or are randomly assigned one if they have no preference. The study measures mood, stress levels, physical function before/after the intervention and at a 6-month follow-up.
What are the potential side effects?
Since MBCR involves mindfulness practices and TCQ includes gentle movements focused on breath control and flexibility there are minimal risks involved. However participants may experience emotional discomfort when discussing personal experiences during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention, within 3 weeks of completion of the intervention, 6-month follow up from intervention completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-intervention, within 3 weeks of completion of the intervention, 6-month follow up from intervention completion for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Profile of Mood States - Total Mood Disturbance (POMS-TMD)
Secondary study objectives
Average Diurnal Cortisol Slope
Blood Pressure
Brief Pain Inventory
+16 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

8Treatment groups
Experimental Treatment
Active Control
Group I: Preference: TCQ (im)Experimental Treatment1 Intervention
Individuals with a preference for 'Tai Chi/Qigong (TCQ) for Cancer Patients' randomized to immediate treatment
Group II: Preference: MBCR (im)Experimental Treatment1 Intervention
Individuals with a preference for 'Mindfulness-Based Cancer Recovery (MBCR)' randomized to immediate treatment
Group III: No Preference: TCQ (im)Experimental Treatment1 Intervention
Individuals with no preference randomized to 'Tai Chi/Qigong (TCQ) for Cancer Patients' - immediate
Group IV: No Preference: MBCR (im)Experimental Treatment1 Intervention
Individuals with no preference randomized to 'Mindfulness-Based Cancer Recovery (MBCR)' - immediate
Group V: Preference: MBCR (wl)Active Control1 Intervention
Individuals with a preference for 'Mindfulness-Based Cancer Recovery (MBCR)' randomized to waitlist
Group VI: No Preference: MBCR (wl)Active Control1 Intervention
Individuals with no preference randomized to 'Mindfulness-Based Cancer Recovery (MBCR)' - waitlist
Group VII: No Preference: TCQ (wl)Active Control1 Intervention
Individuals with no preference randomized to 'Tai Chi/Qigong (TCQ) for Cancer Patients' - waitlist
Group VIII: Preference: TCQ (wl)Active Control1 Intervention
Individuals with a preference for 'Tai Chi/Qigong (TCQ) for Cancer Patients' randomized to waitlist

Find a Location

Who is running the clinical trial?

Linda E. CarlsonLead Sponsor
University of CalgaryOTHER
809 Previous Clinical Trials
885,783 Total Patients Enrolled
Alberta Health servicesOTHER
163 Previous Clinical Trials
652,058 Total Patients Enrolled

Media Library

Mindfulness Based Cancer Recovery (MBCR) Clinical Trial Eligibility Overview. Trial Name: NCT02801123 — N/A
Cancer Research Study Groups: Preference: MBCR (im), Preference: TCQ (im), Preference: MBCR (wl), No Preference: MBCR (im), No Preference: TCQ (im), No Preference: MBCR (wl), No Preference: TCQ (wl), Preference: TCQ (wl)
Cancer Clinical Trial 2023: Mindfulness Based Cancer Recovery (MBCR) Highlights & Side Effects. Trial Name: NCT02801123 — N/A
Mindfulness Based Cancer Recovery (MBCR) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02801123 — N/A
~65 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top